
Get exclusive money-saving offers and guides
Straight to your inbox
Updated
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Integrated Research Limited is a software-application business based in Australia. Integrated Research shares (IRI) are listed on the Australian Securities Exchange (ASX) and all prices are listed in Australian Dollars. Integrated Research has a trailing 12-month revenue of around $110.9 million..
Our top pick for
US stocks
Our top pick for
Cheap broker fees
Our top pick for
Long-term investing
52-week range | $2.1707 - $4.8767 |
---|---|
50-day moving average | $2.8447 |
200-day moving average | $3.6137 |
Target price | $2.6 |
PE ratio | 18.2734 |
Dividend yield | $0.07 (2.95%) |
Earnings per share (TTM) | $0.139 |
Standard brokerage - Australian shares
Competitive broker fees on Australian and international shares
Important: Share trading carries risk of capital loss.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the close of A$2.54 on 2021-01-22
1 week (2021-01-18) | 1.20% |
---|---|
1 month (2020-12-24) | -13.90% |
3 months (2020-10-23) | -31.35% |
6 months (2020-07-24) | -34.70% |
1 year (2020-01-24) | -13.31% |
---|---|
2 years (2019-01-25) | 4.10% |
3 years (2018-01-25) | -33.68% |
5 years (2016-01-25) | 20.95% |
Valuing Integrated Research stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Integrated Research 's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Integrated Research 's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 18x. In other words, Integrated Research shares trade at around 18x recent earnings.
That's relatively low compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Integrated Research 's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $33.9 million.
The EBITDA is a measure of a Integrated Research 's overall financial performance and is widely used to measure a its profitability.
Revenue TTM | $110.9 million |
---|---|
Operating margin TTM | 29.51% |
Gross profit TTM | $110.9 million |
Return on assets TTM | 16.15% |
Return on equity TTM | 31.58% |
Profit margin | 21.69% |
Book value | 0.48 |
Market capitalisation | $437.3 million |
TTM: trailing 12 months
Dividend payout ratio: 51.79% of net profits
Recently Integrated Research has paid out, on average, around 51.79% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 2.95% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Integrated Research shareholders could enjoy a 2.95% return on their shares, in the form of dividend payments. In Integrated Research 's case, that would currently equate to about A$0.07 per share.
Integrated Research 's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
The latest dividend was paid out to all shareholders who bought their shares by 2 September 2020 (the "ex-dividend date").
Over the last 12 months, Integrated Research 's shares have ranged in value from as little as $2.1707 up to $4.8767. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Integrated Research 's is 0.5689. This would suggest that Integrated Research 's shares are less volatile than average (for this exchange).
Integrated Research Limited designs, develops, implements, and sells systems and applications management computer software for business-critical computing, unified communication networks, and payment networks in the Americas, Europe, and the Asia Pacific. The company offers Prognosis, an integrated suite of monitoring and management software designed to give an organization's management and technical personnel operational insight into the HP NonStop platform, distributed system servers, unified communications, payment environments, and the business applications that run on these platforms. It also provides testing, maintenance, and software as a service solutions, as well as professional services. The company serves stock exchanges, banks, credit card companies, telecommunications carriers, service providers, and manufacturing companies through sales offices, as well as through a distribution network. Integrated Research Limited was founded in 1988 and is based in North Sydney, Australia.
Steps to owning and managing Vanguard Australian Fixed Interest Index ETF units.
Steps to owning and managing Vanguard Ethically Conscious Global Aggregate Bond Index (Hedged) ETF units.
Steps to owning and managing ETFS Morningstar Global Technology ETF units.
Steps to owning and managing BetaShares Global Quality Leaders (Currency Hedged) ETF units.
Steps to owning and managing ETFS ROBO Global Robotics and Automation ETF units.
Steps to owning and managing ETFS FANG+ ETF units.
Steps to owning and managing ETFS S&P Biotech ETF units.
Steps to owning and managing ETFS Reliance India Nifty 50 ETF units.
Steps to owning and managing BetaShares India Quality ETF units.